StockWatch
·
HomeLiveWeekly
Other Pharmaceuticals
DisruptionJul 29, 2026, 04:12 PM

Synergy CHC Loses Costco Contract, 58% of 2025 Revenue

AI Summary

Synergy CHC Corp. announced that Costco Wholesale Corporation will discontinue carrying its FOCUSfactor products. This decision is expected to have a material adverse effect on Synergy CHC's business, as Costco represented approximately 58% of the company's net revenue in fiscal year 2025. The company is currently evaluating financing and other strategic alternatives to address the impact.

Key Highlights

  • Costco Wholesale Corporation will discontinue carrying Synergy CHC's FOCUSfactor products.
  • Costco has been a significant customer for Synergy CHC for over 16 years.
  • Costco accounted for approximately 58% of Synergy CHC's net revenue in fiscal year 2025.
  • The company expects a material adverse effect on its business, results of operations, liquidity, and financial condition.
  • Synergy CHC is evaluating available financing and other strategic alternatives.
  • The decision was communicated to Synergy CHC on July 15, 2026.
View SEC Filing
SNYR
Other Pharmaceuticals
Synergy CHC Corp.

Price Impact

More from SNYR

AGM/EGMJun 29, 4:21 PM

Synergy CHC Stockholders Approve Reverse Split, Equity Plan

DelistingMay 18, 9:08 AM

Synergy CHC Corp. Receives Nasdaq Delisting Notice

InvestmentMay 15, 5:13 PM

Synergy CHC Files S-1 for Resale of 101.7M Shares; May Raise $36M

More in Disruption

FURYJul 15, 5:16 PM

Fury Gold Mines Evacuates Camp Due to Wildfire, Halts Exploration

FURYJul 15, 5:02 PM

Fury Gold Mines Evacuates Eau Claire Camp Due to Forest Fire

RDYJul 15, 9:51 AM

Dr. Reddy's Halts Semaglutide Injection Supply Due to Impurity